News

Verisk Analytics Reports Stellar Results for Third Quarter

Verisk Analytics Reports Stellar Results for Third Quarter

Impressive Financial Performance from Verisk Analytics

Verisk Analytics, Inc. recently announced its financial performance for the third quarter of 2024, showcasing a remarkable growth trajectory. The company reported consolidated revenues of $725 million, a 7.0% increase compared to the previous year, and a 6.8% rise on an organic constant currency (OCC) basis. This significant growth underscores the strength of Verisk's subscription-based business model, positioning it as a leading data analytics provider in the insurance industry.

Strong Income and Cash Flow Results

During this quarter, income from continuing operations surged to $220 million, reflecting a 17.4% increase. Adjusted EBITDA, a non-GAAP measure recognized for highlighting operational performance, also rose to $401 million, marking a 9.4% increase and offering a 54.6% adjusted EBITDA margin for the trailing twelve months. Notably, the net cash generated from operating activities reached $296 million, representing an 18.4% year-over-year growth. Free cash flow amounted to $241 million, demonstrating Verisk's efficiency and commitment to returning value to shareholders.

Dividend and Share Repurchase Initiatives

Verisk’s Board of Directors has announced a cash dividend of 39 cents per share, scheduled for distribution on December 31, 2024. This dividend reflects an impressive 15% increase from last year, showcasing the company’s robust financial health and focus on returning capital to its investors. Additionally, during the third quarter, Verisk executed a $400 million accelerated share repurchase program, resulting in the repurchase of over 1.5 million shares at an average price of $263.92.

Strategic Initiatives Supporting Growth

Lee Shavel, the president and CEO of Verisk, emphasized the effective strategic dialogues that foster stronger relationships and generate new opportunities within their client base. This quarter proved pivotal as they continued to innovate and invest significantly in enhancing operational efficiencies within the insurance sector. Verisk's commitment to technological advancement amidst various challenges faced by the industry was also highlighted, showcasing the company's proactive approach to ensuring growth and profitability.

Driving Growth Through Subscription Services

Verisk's growth is largely attributed to the increasing strength in its subscription services. The OCC revenue rose by 6.8%, primarily driven by sequential improvements in underwriting and claims processes. Strong performance was noted within both the underwriting and claims segments, bolstered by a focus on anti-fraud solutions and enhanced service delivery. The investment in technological innovation continues to position Verisk as a key partner for clients navigating the complexities of the insurance landscape.

Looking Ahead: Financial Guidance for 2024

Looking forward, Verisk remains optimistic about its growth pathways. The company maintains its financial outlook for 2024, projecting revenues between $2.84 billion and $2.9 billion, with anticipated adjusted EBITDA of approximately $1.54 billion to $1.6 billion. This guidance indicates a consistent approach to operational excellence and sustained profit generation as it adapts to market dynamics.

Frequently Asked Questions

What were Verisk's total revenues for Q3 2024?

Verisk reported total revenues of $725 million for the third quarter of 2024, representing a 7.0% increase year-over-year.

How much was the cash dividend declared by Verisk?

The Board approved a cash dividend of 39 cents per share, reflecting a 15% increase from the previous year's distribution.

What is the reason behind the increase in income from continuing operations?

The increase to $220 million, up 17.4%, was driven by strong revenue growth and effective cost management.

How did Verisk's share repurchase program impact its earnings?

During Q3 2024, Verisk repurchased $400 million worth of shares, which contributed to a lower average share count, positively impacting earnings per share.

What is the focus of Verisk's strategic initiatives?

Verisk's strategic initiatives focus on enhancing operational efficiency, client engagement, and innovation within the insurance sector to address emerging challenges.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 5

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Cutting-Edge Innovations from GrowGeneration at Cultivate'25

Updated Category News Views 135

Exciting Innovations at Cultivate'25 GrowGeneration Corp. (NASDAQ: GRWG), a leading name in hydroponic retail, is gearing up to demonstrate its cutting-edge products at Cultivate'25. This premier horticulture trade show is a golden opportunity for lawn and garden professionals, greenhouses, and nurseries to witness firsthand the innovations that are transforming...

Continue Reading
Cellectar Biosciences Showcases Breakthrough Cancer Treatment Data

Updated Category News Views 153

Innovative Cancer Treatment Presentation by Cellectar Biosciences Cellectar Biosciences, Inc. (NASDAQ: CLRB), a pioneering biopharmaceutical entity, is making waves in the field of oncology with its recent presentation at a renowned cancer research conference. The company announced its positive preclinical data for CLR 121225, showcasing its potential as a groundbreaking...

Continue Reading
Fidelity National Financial's Strategic $500 Million Notes Offering

Updated Category News Views 58

Fidelity National Financial Secures $500 Million in Senior Notes Fidelity National Financial (NYSE: FNF), a prominent player in title insurance and transaction services, has made waves with the recent announcement of a successful public offering of $500 million in senior notes via its subsidiary, F&G Annuities & Life, Inc. This strategic move is poised to bolster the...

Continue Reading
Centering Healthcare Institute Gains Investment to Enhance Care Model

Updated Category News Views 65

Centering Healthcare Institute Secures $7.6 Million Investment Centering Healthcare Institute (CHI) has announced an exciting new chapter in its mission to enhance healthcare delivery with a recent investment of $7.6 million from The Studio @ Blue Meridian. This significant funding will allow CHI to implement a strategic three-year plan focused on scaling its services and...

Continue Reading
Leadership Changes at Ring Energy: New CFO Transition Strategy

Updated Category News Views 275

Ring Energy's Recent Leadership Transition Ring Energy, Inc. has recently made headlines with the announcement of a significant shift in its leadership. The company has confirmed that Travis T. Thomas, the former Chief Financial Officer (CFO), has resigned from his position to pursue new opportunities. This transition marks an important moment for the organization and...

Continue Reading